MARIE-LAURIE VANEGAS: Open Payments
NPI 1811573827 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,723 in 152 payments from 27 companies in 2025. Trend: 2023 $2,661 · 2024 $3,204 · 2025 $4,723
Food & beverage: $4,723
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $625 |
| Xeris Pharmaceuticals, Inc. | 9 | $399 |
| Amgen Inc. | 14 | $362 |
| CeQur Corporation | 1 | $351 |
| Lilly USA, LLC | 16 | $338 |
| Insulet Corporation | 8 | $284 |
| Mannkind Corporation | 15 | $269 |
| Corcept Therapeutics | 10 | $266 |
| Tandem Diabetes Care, Inc. | 10 | $243 |
| Neurocrine BioSciences, Inc. | 3 | $196 |
Products named: GVOKE HYPOPEN, CeQur Simplicity, Ozempic, Wegovy, Omnipod, AFREZZA, Korlym, t:slim X2 Insulin Pump with Control-IQ.
Industry payments across FL — which companies pay providers there.
